Cargando…

ITPR1 autoimmunity: Frequency, neurologic phenotype, and cancer association

Detalles Bibliográficos
Autores principales:	Alfugham, Nora, Gadoth, Avi, Lennon, Vanda A., Komorowski, Lars, Scharf, Madeleine, Hinson, Shannon, McKeon, Andrew, Pittock, Sean J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Clinical/Scientific Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778826/ https://www.ncbi.nlm.nih.gov/pubmed/29379822 http://dx.doi.org/10.1212/NXI.0000000000000418

Ejemplares similares

A comparison of tissue-based and recombinant protein–based assays for detecting PCA-Tr/DNER-IgG
por: Alfugham, Nora, et al.
Publicado: (2016)

Neurochondrin neurological autoimmunity
por: Shelly, Shahar, et al.
Publicado: (2019)

IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients
por: Honorat, Josephe A., et al.
Publicado: (2017)

Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies
por: Berzero, Giulia, et al.
Publicado: (2017)

Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG
por: Honorat, Josephe A., et al.
Publicado: (2019)

Contactin-1 autoimmunity: Serologic, neurologic, and pathologic correlates
por: Dubey, Divyanshu, et al.
Publicado: (2020)

Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity
por: Zekeridou, Anastasia, et al.
Publicado: (2019)

Posttransplant autoimmune encephalitis
por: Cohen, Devon A., et al.
Publicado: (2018)

Elevated LGI1‐IgG CSF index predicts worse neurological outcome
por: Gadoth, Avi, et al.
Publicado: (2018)

Dacrystic seizures—a cry for help
por: Gadoth, Avi, et al.
Publicado: (2017)

Paraneoplastic neuronal intermediate filament autoimmunity
por: Basal, Eati, et al.
Publicado: (2018)

Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine‐rich glioma‐inactivated protein 1
por: Feyissa, Anteneh M., et al.
Publicado: (2018)

Subacute encephalitis with recovery in IgLON5 autoimmunity
por: Ramanan, Vijay K., et al.
Publicado: (2018)

Episodic ataxia in CASPR2 autoimmunity
por: López Chiriboga, A. Sebastian, et al.
Publicado: (2018)

Opsoclonus-Myoclonus Syndrome during Rituximab Treatment for Autoimmune Autonomic Ganglionopathy
por: Dumitrascu, Oana M., et al.
Publicado: (2017)

Clinical utility of testing AQP4-IgG in CSF: Guidance for physicians
por: Majed, Masoud, et al.
Publicado: (2016)

Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders
por: Hinson, Shannon R., et al.
Publicado: (2018)

Autoimmune septin-5 cerebellar ataxia
por: Honorat, Josephe A., et al.
Publicado: (2018)

GABA(A) receptor autoimmunity: A multicenter experience
por: O'Connor, Kevin, et al.
Publicado: (2019)

Overnight loss of pigmented hair in autoimmune autonomic neuropathy treated with IVIg
por: Turner, Lindsey E., et al.
Publicado: (2019)

Population-Based Epidemiology Study of Paraneoplastic Neurologic Syndromes
por: Shah, Shailee, et al.
Publicado: (2021)

Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease
por: McKeon, Andrew, et al.
Publicado: (2023)

Phenotypic presentations of paraneoplastic neuropathies associated with MAP1B-IgG
por: Jitprapaikulsan, Jiraporn, et al.
Publicado: (2020)

Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia
por: Jarius, Sven, et al.
Publicado: (2014)

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
por: Lennon, Vanda A., et al.
Publicado: (2005)

Frequency and Referral Patterns of Neural Antibody Studies During the COVID-19 Pandemic: Experience From an Autoimmune Neurology Center
por: Ariño, Helena, et al.
Publicado: (2023)

Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy
por: Apiwattanakul, Metha, et al.
Publicado: (2016)

CDR2 and CDR2L line blot performance in PCA-1/anti-Yo paraneoplastic autoimmunity
por: Vorasoot, Nisa, et al.
Publicado: (2023)

Randomized Placebo‐Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy
por: Dubey, Divyanshu, et al.
Publicado: (2019)

Clinical spectrum of high-titre GAD65 antibodies
por: Budhram, Adrian, et al.
Publicado: (2021)

Commentary: Detection Methods for Autoantibodies in Suspected Autoimmune Encephalitis
por: Gadoth, Avi
Publicado: (2019)

Paraneoplastic autoimmunity and small‐cell lung cancer: Neurological and serological accompaniments
por: Zekeridou, Anastasia, et al.
Publicado: (2019)

Frequency of New or Enlarging Lesions on MRI Outside of Clinical Attacks in Patients With MOG-Antibody–Associated Disease
por: Syc-Mazurek, Stephanie B., et al.
Publicado: (2022)

Case Report: Innate Immune System Challenge Unleashes Paraneoplastic Neurological Autoimmunity
por: Zhu, Mingqin, et al.
Publicado: (2020)

Anti–Interleukin-6 and Janus Kinase Inhibitors for Severe Neurologic Toxicity of Checkpoint Inhibitors
por: Picca, Alberto, et al.
Publicado: (2021)

Autoimmune Encephalitis Criteria in Clinical Practice
por: Orozco, Emma, et al.
Publicado: (2023)

Subacute Horizontal Diplopia, Jaw Dystonia, and Laryngospasm
por: Tisavipat, Nanthaya, et al.
Publicado: (2023)

Aquaporin-4–binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2
por: Hinson, Shannon R., et al.
Publicado: (2008)

Neurologic manifestations in an infant with COVID-19
por: Dugue, Rachelle, et al.
Publicado: (2020)

Brain dysfunction and thyroid antibodies: autoimmune diagnosis and misdiagnosis
por: Valencia-Sanchez, Cristina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i8nojmn4tp3u90oj18ne3f1pg8